FDA Inspection
Department of Defense - Air ForceDepartment of Defense - Air Force – FDA Inspection, Sep 26, 2019
Record Details
This FDA Inspection record concerns Department of Defense - Air Force, with an inspection on September 26, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 77d19369-bacf-4f49-b4f0-b8f9bf619ed4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1103404
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 606.160(a)(2)Determination of lot numbers and supplies
- 21 CFR 610.47(a)(3)Notify Consignees [Collecting Establishment]
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Department of Defense - Air Force
6| Date | Classification | Office | Project area |
|---|---|---|---|
| April 14, 2025 | VAI | Cincinnati District Office | Blood and Blood Products |
| March 30, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| September 19, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 7, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 21, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Department of Defense - Air Force
- FDA Inspection 1266836 - 2025-04-14
- FDA Inspection 1166032 - 2022-03-30
- FDA Inspection 1026018 - 2017-09-19
- FDA Inspection 937774 - 2015-08-07
- FDA Inspection 812221 - 2012-12-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.